Cooperative Agreement U24FD005664

Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a Project Grant award of $854,803 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 13, 2025, with an anticipated completion date of May 31, 2030. The award funds the development of a comprehensive, curated data repository for indirect calorimetry experiments in mice...

Project Grant Award Summary Western Michigan University Homer Stryker M.D. School of Medicine received a $342,002 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with a completion date of August 31, 2027. This research initiative focuses on developing cellular tools and models to study PKD1 (polycystin-1) regulation in autosomal...

This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) federal grant award (CFDA 47.070) of $200,000 to the Trustees of the Stevens Institute of Technology will support the development of a flexible and open-resource medical knowledge base called FORMED. The goal is to create a comprehensive, public-oriented database covering a wide range of diseases, conditions, and medications with detailed information on symptoms, causes, and treatments. The project...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $178,000.00 to The Children's Hospital of Philadelphia (CHOP) to design and validate a Pelizaeus Merzbacher Disease (PMD) severity scale. The goal is to develop a clinician-reported outcome measure that can be used to stratify PMD patients by disease severity, particularly early in the disease...

Federal Project Grant Award Summary Massachusetts General Hospital received a $396,604 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 15, 2025, with a completion date of March 31, 2030. The award funds research to advance patient-centered care for individuals with chronic kidney disease (CKD) through the systematic integration of...

Amdx Prognostx Inc. received a $791,145 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases within the Department of Health and Human Services. The award falls under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), which promotes biomedical research to improve understanding and treatment of diabetes, digestive, and kidney diseases. Under this award, Amdx Prognostx will develop an enzyme-linked immunosorbent assay...

Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $824,078 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through January 31, 2030. The award supports a comprehensive research initiative to characterize drug-induced pancreatic injury (DIPI) through integrated computational and...

Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $659,358 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 4, 2025, with completion targeted for June 30, 2030. The grant funds basic biomedical research investigating the mechanisms underlying APOL1 (Apolipoprotein L1) nephropathy, a genetic form of kidney...

Federal Project Grant Award Summary Biosettia Inc. received a $291,949 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for August 31, 2026. The research deliverables focus on developing and validating endogenous retrovirus (ERV) GAG gene variants as biomarkers for Type 1 Diabetes (T1D) through deep...

Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Trustees of Columbia University in the City of New York $739,540 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 1, 2025, with completion targeted for June 30, 2030. This Project Grant supports the development of a third-generation genome-wide polygenic score (GPS) for chronic kidney disease (CKD) risk...